DOYLE WILLIAM F
Executive Chairman
DOYLE WILLIAM F has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, DOYLE WILLIAM F is listed as Executive Chairman at NovoCure Ltd. Inside the rolling window, DOYLE WILLIAM F reported no open-market purchases and 1 open-market sale totaling $933K in NVCR.
Companies traded
Other insiders at NVCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$933K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DOYLE WILLIAM F made?
DOYLE WILLIAM F has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does DOYLE WILLIAM F trade?
DOYLE WILLIAM F has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was DOYLE WILLIAM F's most recent SEC Form 4 filing?
DOYLE WILLIAM F's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is DOYLE WILLIAM F's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, DOYLE WILLIAM F is listed as Executive Chairman.
What is DOYLE WILLIAM F's total buy and sell value in the current window?
Inside the rolling retention window, DOYLE WILLIAM F bought $0 and sold $933K based on SEC Form 4 filings.
What was DOYLE WILLIAM F's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 71,887 NVCR shares on 2026-03-03, worth $933K, per SEC Form 4 filings.